Document is current
Any future updates will be listed below
-
Authors
Azizi, F.
Amouzegar, A.
Abdi, H.
Tohidi, M.
Masoumi, S.
Khalili, D.
Mehrabi, Y.
Zadehvakili, A.
Hedayati, M.
Momenan, A. A.
Mehran, L.
- License Information
-
More Information
Article History
Received: 20 October 2024
Accepted: 19 June 2025
First Online: 1 July 2025
Declarations
:
: The study design was registered in the Iranian Registry of Clinical Trials, IRCT20100922004794N12, and was carried out in compliance with the ethical principles outlined in the Declaration of Helsinki. Ethical approval for this study, including provisions for genetic testing and biobanking, was obtained from the National Research Council of the Islamic Republic of Iran (IR.SBMU.ENDOCRINE.REC.1403.061), the Human Research Review Committee of the Endocrine Research Center, Shahid Beheshti University, Tehran, Iran, as indicated in the approved protocol and participant consent forms. Trial participants sign informed consent forms at baseline, and their personal information remains strictly confidential. We confirm that no biological specimens will be stored after the completion of the study. All samples will be used solely for the purposes outlined in the study protocol and will be disposedof according to institutional and ethical guidelines.
: Not applicable.
: The authors declare that they have no competing interests.
